ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
Authors:
Open Access
- 4 October 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 10, 790
Abstract
Purpose: Kinase insert domain receptor (KDR) is the primary vascular endothelial growth factor receptor mediating survival, growth, and migration of endothelial cells and is expressed also in various tumor cells through autocrine production. The PI3K/Pten pathway is one of the downstream signalings affected by KDR activation and most commonly altered in breast cancer. Here, we investigate whether KDR expression is associated with members in PI3K/Pten signaling on the prognosis of breast cancer patients. Methods: PI3K/Pten pathway components were defined by mapping The Cancer Genome Atlas (TCGA) protein data to the KEGG database complemented by literature searching, accounting for 36 proteins subject to the interaction analysis with KDR on breast cancer patient survival. The identified interaction gene pair was subjected to in vitro validation following functional analysis. Results: Anillin (ANLN) was found to interact with KDR at translational and transcriptional levels using the public TCGA protein expression data and five gene expression datasets. Favorable prognosis corresponds to high protein but low gene expression of ANLN when KDR is highly expressed. Externally modulating cells toward low ANLN and high KDR gene expression was shown to transit triple negative cells toward a luminal-like state with increased level of ER and elevated sensitivity to Tamoxifen. Conclusion: Our study proposes a two-gene panel prognostic of breast cancer survival and a novel therapeutic strategy for triple negative breast cancer control via transiting cancer cells towards a luminal-like state sensitive to established targeted therapy.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (grant number: BK20161130)
- Six Talent Peaks Project in Jiangsu Province (grant number: SWYY-128)
This publication has 21 references indexed in Scilit:
- Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting RegenerationGastroenterology, 2018
- The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomesOncotarget, 2017
- ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancerBMC Cancer, 2016
- Monoclonal Antibody against the Ectodomain of E-Cadherin (DECMA-1) Suppresses Breast Carcinogenesis: Involvement of the HER/PI3K/Akt/mTOR and IAP PathwaysClinical Cancer Research, 2013
- Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomideCell Cycle, 2013
- EpCAM‐associated claudin‐7 supports lymphatic spread and drug resistance in rat pancreatic cancerInternational Journal of Cancer, 2013
- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast CancerCancer Research, 2011
- The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditionsClinical Science, 2005
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- LEARNING BY STATISTICAL COOPERATION OF SELF-INTERESTED NEURON-LIKE COMPUTING ELEMENTS1985